Drug Security Forum

Drug Security: Humanity at the Heart of Collaboration

15 Jun , 16:45–18:45
‘Ensuring Drug Security’ Russian Pharmaceutical Forum
Plenary session
Congress Centre, conference hall D1

For Russia, drug security is currently a top priority in the healthcare sector and a precondition for the country to reach an entirely new level given the realities of the current challenges. The government’s immediate agenda includes maintaining the availability of medicines, ensuring the financial stability and technological independence of pharmaceutical industries, and fulfilling state guarantees for the provision of drugs to society. In a country with stable drug security, each citizen must be sure that his/her life and health are reliably protected. Such confidence is primarily manifested in the trust of society and people’s approval of the actions of state institutions. Today, it is not only crucial to unite the key regulators, the expert community, and society and establish the openness and transparency of various processes, but also to build a space for understanding and cooperation. People’s health and lives are a primary focus of the laws of humanism and go beyond political boundaries. What solutions will get the healthcare and medical supply industry out from the pressure of sanctions? What strategies for the import independence of the pharmaceutical industry are protecting the government’s interests? How can the state and society build a dialogue towards trust and cooperation? What is the best way to ensure national drug security and guarantee that Russian citizens regularly have high-quality and effective drugs available to them?

Sergey Brilev, President, The Global Energy Association

Ikhtiyar Aslanov, Head of Regional Delegation for the Russian Federation and the Republic of Belarus, International Committee of the Red Cross
Mariangela Batista Galvao Simao, Assistant Director-General, Access to Medicines and Health Products, World Health Organization (online)
Mikhail Murashko, Minister of Health of the Russian Federation
Aleksandr Petrov, Chairman of the Subcommittee on Medicines, Development of the Pharmaceutical and Medical Industry of the State Duma of the Federal Assembly of the Russian Federation for Health Protection
Alla Samoylova, Head, Federal Service for Surveillance in Healthcare (Roszdravnadzor)
Veronika Skvortsova, Head, Federal Medical-Biological Agency of the Russian Federation
Tadzio Schilling, Chief Executive Officer, Association of European Businesses (АЕВ)
Evgeny Shlyakhto, Director General, Almazov National Medical Research Centre; President, All-Russian Non-Governmental Organization "Russian Society of Cardiology"